February 4, 2013
Newron together with NeuroNova receives €2.5m Strategic Translation Award from Wellcome Trust to develop experimental drug candidate for ALS
December 17, 2012
Newron closes acquisition of NeuroNova
© NeuroNova AB, Sweden, Tel: +46 (0)8 786 0900, Email:
Site last updated: Wednesday 8 May 2013
More about our Projects
NeuroNova’s business strategy centers on developing novel therapeutic products based on neurogenesis in areas of high unmet medical need in neurodegenerative diseases.
More about business development.